HRT Financial’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $742K | Buy |
+139,900
| New | +$742K | ﹤0.01% | 1195 |
|
|
2024
Q4 | – | Sell |
-22,193
| Closed | -$607K | – | 2710 |
|
|
2024
Q3 | $607K | Buy |
+22,193
| New | +$607K | ﹤0.01% | 1380 |
|
|
2023
Q4 | – | Sell |
-70,472
| Closed | -$1.13M | – | 2595 |
|
|
2023
Q3 | $1.13M | Buy |
+70,472
| New | +$1.13M | 0.01% | 818 |
|
|
2023
Q2 | – | Sell |
-103,309
| Closed | -$2.4M | – | 2767 |
|
|
2023
Q1 | $2.4M | Buy |
103,309
+65,916
| +176% | +$1.53M | 0.03% | 482 |
|
|
2022
Q4 | $542K | Buy |
+37,393
| New | +$542K | 0.01% | 1253 |
|
|
2022
Q2 | – | Sell |
-41,813
| Closed | -$1.05M | – | 3268 |
|
|
2022
Q1 | $1.05M | Buy |
+41,813
| New | +$1.05M | 0.01% | 881 |
|
|
2021
Q1 | – | Sell |
-28,227
| Closed | -$558K | – | 2773 |
|
|
2020
Q4 | $558K | Sell |
28,227
-10,797
| -28% | -$213K | 0.01% | 919 |
|
|
2020
Q3 | $508K | Buy |
+39,024
| New | +$508K | 0.01% | 800 |
|